Probability of overall survival. Survival for all patients in the trial is shown as the solid black line (48% 3-year overall survival). Patients without BM morphologic or radiographic evidence of disease at the time of transplantation are shown with the dashed line (75% 3-year overall survival). Patients with BM or radiographic evidence of disease are shown in the dotted line (27% 3-year overall survival).